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ABSTRACT
Objective: The aim of this study was to determine the predictive factors of postoperative 
morbidity of patients who have undergone a radical trachelectomy (RT) for early-stage 
cervical cancer and to assess the oncologic outcomes.
Methods: We retrospectively analysed the data of 2 prospective trials on sentinel node biopsy 
for cervical cancer (SENTICOL I and II). Patients having a RT for early-stage cervical cancer 
with negative sentinel lymph node and safe margins, were included.
Results: Forty-nine patients met the inclusion criteria. Forty-five patients had a laparoscopic-
assisted vaginal technique and 4 patients a total laparoscopic technique. The median age 
was 32 years (range, 22–46 years). 83.7% of patients had a stage IB1 disease. There were 
63.3% squamous cell carcinomas and 34.7% adenocarcinomas. The median follow-up 
was 46 months (range, 1–85 months). Two patients (3.3%) had a severe postoperative 
complication (Clavien-Dindo ≥III and/or CTCAE ≥3). The main postoperative complications 
were urinary (28.6%), lymphovascular (26.5%) and neurologic (14.3%). On a multivariate 
analysis, postoperative complications were significantly associated with history of pelvic 
surgery and IB1 International Federation of Gynecology and Obstetrics stage. Inclusion in 
high surgical skills centers decrease the risk of postoperative complications. During the 
follow-up, 3 patients (6.1%) had a local recurrence and one patient died from a breast cancer. 
Between group with complications and group without any complications, overall survival and 
recurrence-free survival did not significantly differ at 5-year of follow-up.
Conclusion: RT has few severe postoperative complications and appears as a safe alternative 
to spare fertility of young patients. To guarantee best surgical outcomes, patients should be 
referred to expert center.
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INTRODUCTION
The radical vaginal trachelectomy was first described by Dargent in 1994 and the first series of 
56 patients was published in 2000 [1]. Radical trachelectomy (RT) is a conservative treatment 
for early-stage cervical cancer consisting in removing the uterine cervix, the parametrium 
and sparing the remaining uterus. Indications are not so rare since about 42% of early stages 
are diagnosed before 40 years old [2]. Moreover, 48% of women younger than 40 years, 
who underwent radical hysterectomy, were in fact eligible for trachelectomy [3]. Criteria for 
performing RT were proposed in 1998 and in the last European Society of Gynaecological 
Oncology (ESGO) guidelines: desire to preserve fertility; of reproductive age; usual histologic 
type including squamous carcinoma or adenocarcinoma histology; International Federation 
of Gynecology and Obstetrics (FIGO) stage IA1 with lymphovascular space invasion, IA2, 
or IB1; tumor size less than 20 mm with limited endocervical extension; and no evidence of 
lymph node metastasis [4,5].
To date, more than 2,700 cases have been published and more than 900 deliveries have 
been reported [6]. The feasibility of RT with vaginal, abdominal, laparoscopic and 
robotic technique have been proven with similar oncologic outcomes [7-11]. However, few 
prospective data are available on the postoperative morbidity after RT and their consequences 
on oncologic outcomes.
The main objective of this study was to assess the postoperative morbidity after RT for 
early-stage cervical cancer. The secondary objectives were to determine risk factors of 
postoperative complications and their impact on oncologic outcomes.
MATERIALS AND METHODS
1. Population study
We realised an ancillary study on the database of 2 prospective French multicentric studies 
on sentinel lymph node (SLN) biopsy (SENTICOL I and II). Patients with early cervical 
cancer (stage IA1 with lymphovascular emboli to stage IIA1), no suspicious nodes at 
preoperative imaging and squamous cell, adenocarcinoma or adenosquamous histology were 
prospectively included.
SENTICOL I was a prospective multicenter study assessing the diagnostic value of SLN 
biopsy in early-stage cervical cancer. One hundred and forty-five patients were enrolled 
between January 2005 and May 2007 and 139 patients were included in a modified intention-
to-diagnose analysis [12]. SENTICOL II was a prospective randomized multicenter study 
assessing morbidity and quality of life [13]. Two hundred and sixty-seven patients were 
enrolled and 206 patients with negative SLN at frozen-section examination were randomised 
between SLN biopsy only (105 patients) or SLN biopsy with full pelvic lymph node dissection 
(101 patients). In both studies, postoperative complications were prospectively recorded. A 
radical hysterectomy or a RT were performed in case of negative SLN at frozen-examination. 
Twenty-three centers participated to the 2 studies.
We performed a retrospective analysis of the two databases. We included cases that 
underwent a RT. Young patients who aimed to spare their fertility with tumor size smaller 
than 20 mm were eligible for RT in case of negative SLN at frozen section (FS). Patients who 
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had only node staging, had non-radical surgery (simple trachelectomy), patients with positive 
SLN, extracervical lesion or positive margins were excluded.
The laparoscopic-assisted vaginal RT technique has already been described thoroughly elsewhere 
[1,14] and only few patients had a non-vaginal surgical approach. Shortly, the procedure started 
with a laparoscopic pelvic lymph node dissection. In Senticol 1, patients had a SLN biopsy and 
had systematically an additional pelvic lymphadenectomy whereas in Senticol 2, patients had 
a SLN biopsy and an additional pelvic lymphadenectomy according to the randomisation. The 
nodal dissection was performed through transperitoneal approach. Removed lymph nodes (or 
only the SLNs) had a FS. In case of negative FS, RT was realised through a vaginal approach. The 
main steps of the procedure were: dissection of a 2-cm vaginal cuff, dissection of the bladder 
and the ureters, opening the Douglas pouch and bilateral proximal parametrectomy after 
identification of the uterine artery. The cervix was cut 5 mm below the isthmus. The specimen 
was sent for immediate pathological examination, for checking free endocervical margin. Then 
the pouch of Douglas was closed, and a permanent cerclage was put at the level of the isthmus. 
Finally, the vagino-isthmic anastomosis was performed.
2. Data analysis
Data were extracted from the two prospective data bases. For each patient, we reviewed 
demographic characteristics (age at diagnosis, body mass index [BMI], and parity), surgical 
history, and clinical data (preoperative loop electrical excision procedure [LEEP], FIGO stage). 
We noted the results of preoperative biopsy and the tumor size at preoperative imaging. Operative 
records were reviewed, and data were collected about the type of surgical approach, the type 
of surgery performed, the type of lymph node staging (SLN biopsy only or additional pelvic 
lymphadenectomy), and the number of lymph node removed. Pathological data was reviewed 
and included tumor histology, lymphovascular space invasion, nodal status, number or removed 
nodes, parametrial status, vaginal margin status, surgical margin status, and tumor size.
Intraoperative and postoperative complications were recorded according to time of onset 
(early complications ≤30 days after surgery and late complications >30 days after surgery). 
Levels of complications were assessed according to Clavien-Dindo classification for early-
complications and according to the CTCAE classification v4.03 for late complications 
[15]. A severe complication was defined as grade ≥3 in the Clavien-Dindo classification, 
necessitating a radiologic or surgical operation, or as grade ≥3 in the CTCAE classification. 
Given the initial design of SENTICOL I and II, pregnancy rates were not specifically assessed. 
To assess the surgical skills of each center, we defined 2 types of inclusion center according to 
the number of patients included type 1 (<10 patients), and type 2 (>10 patients).
3. Statistical analysis
Morbidity data were described as number (%) for qualitative variables and mean (range) for 
quantitative data. We divided the patients into 2 groups based on presence or absence of 
complications. In order to determine risk factors of postoperative complications, a univariate 
analyse was performed. Qualitative variables were compared by applying the χ2 test (or 
Fisher's test if the sample size was too small) and quantitative variables the Student's t-test. 
Values of p lower than 0.05 were considered as significant.
Variables associated with p value lower than 0.2 by univariate analysis were entered into a 
multivariate logistic regression model in order to identify variables independently associated 
with postoperative complications of RT.
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Overall survival and free-recurrence survival were analysed by using Kaplan-Meier analysis 
and compared by applying log-rank test.
Data were recorded in an Excel files and statistical analyses were done using XLStat v19.4 
(AddInsoft, Paris, France) and Stata v13.0 (Stata Corp., College Station, TX, USA).
RESULTS
Between January 2005 and July 2012, 412 patients have been enrolled in SENTICOL I and 
SENTICOL 2 studies in 23 French centers. Forty-nine patients from 8 centers were finally 
included in the present study (Fig. 1).
1. Patient characteristics
The median age was 32 years (22–46) and the median body mass index (BMI) was 20.8 kg/
m2 (15.8–38.2). Patients were nulliparous in 51% of cases (25/49). Most of the patients had 
FIGO stage IB1 disease (83.7%). Thirty-three patients (68.8%) had a previous conisation. The 
majority of patients had squamous cell carcinoma (63.3%), 17 patients had adenocarcinoma 
(34.7%) and one patient had adenosquamous carcinoma (2%). Among the 39 patients who 
had a preoperative imaging, 4 patients (10.3%) had a tumor size larger than 20 mm. The 
sociodemographic and clinical characteristics are shown in Table 1. No patients received 
neoadjuvant brachytherapy.
The laparoscopic-assisted radical vaginal trachelectomy (LARVT) was the main surgical 
approach (45 patients, 91.8%) whereas only 4 patients (8.2%) had total laparoscopic 
approach. No laparoconversion was performed. The mean-length operating time was 264±61 
minutes (165–435).
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SENTICOL I and II cohort
(n=412)
Radical trachelectomy
(n=55)
Final analysis
(n=49)
Excluded patients
Radical hysterectomy (n=277)
Simple hysterectomy (n=10)
Simple trachelectomy (n=4)
No surgery performed (n=54)
Previous subtotal hysterectomy (n=4)
Missing data (n=8)
Excluded patients
SLN positive (n=3)
SLN positive+positive vaginal margin (n=1)
Positive parametrial margin (n=1)
Positive surgical margin (n=1)
Fig. 1. Flow-chart of the population study. 
SLN, sentinel lymph node.
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Table 1. Clinicopathologic and surgical characteristics of patients
Total population (n=49) Values
Type of inclusion center
Type 1 25 (51.0)
Type 2 24 (49.0)
Age (yr)
Median 32 (22–46)
<30 14 (28.6)
≥30 35 (71.4)
BMI (kg/m2)
Median 20.8 (15.8–38.2)
<18.5 7 (14.3)
≥18.5 and <25 31 (63.3)
≥25 and <30 6 (12.2)
≥30 5 (10.2)
Parity
0 25 (51.0)
≥1 24 (49.0)
History of previous pelvic surgery
0 33 (67.3)
≥1 16 (32.7)
FIGO stage
IA1 with emboli 2 (4.1)
IA2 6 (12.2)
IB1 41 (83.7)
Histology
Squamous cell carcinoma 31 (63.3)
Adenocarcinoma 17 (34.7)
Adenosquamous 1 (2.0)
Presence of LVSI in the biopsy
Yes 8 (16.3)
No 38 (77.6)
Not specified 3 (6.1)
Tumor size at preoperative imagery (mm)
≤20 35 (71.4)
>20 4 (8.2)
Not specified 10 (20.4)
Preoperative LEEP
Yes 33 (68.8)
No 16 (31.3)
Type of surgical approach
LARVT 45 (91.8)
Laparoscopy 4 (8.2)
Mean length of operative time (min) 264±61 (165–435)
Type of lymph node staging
SLN alone 14 (28.6)
SLN + PL 35 (71.4)
SLN detection
No SLN 0
Unilateral 2 (4.1)
Bilateral 47 (95.9)
Type of SLN 179
Blue and Hot 124 (69.3)
Hot 32 (17.9)
Blue 23 (12.8)
Topography of SLN 179
Ilio-obturator/External iliac area 148 (82.7)
Common iliac area 21 (11.7)
Parametrial area 7 (3.9)
Promontory area 0
Paraaortic area 3 (1.7)
(continued to the next page)
Fourteen patients (28.6%) had a SLN biopsy alone and 35 (71.4%) had an additional pelvic 
lymphadenectomy. No SLN was found on one side in 2 patients (4.1%) who underwent 
subsequently an ipsilateral complete pelvic lymphadenectomy in the same operation. 
The median number of removed SLN per patient was 3 (1–8). In case of additional pelvic 
lymphadenectomy, the mean number of removed non-SLN per patient was 13 (4–32). Most of 
SLN (82.7%) were found in ilio-obturator or external iliac area (Table 2).
At final pathologic examination, the median maximal size of the tumor was 14 mm (2–30) 
and 8.2% of patients had a tumor size larger than 20 mm. No patients received adjuvant 
chemotherapy or radiotherapy.
2. Perioperative outcomes
Overall, 42 complications were reported in 27 patients (55.1%) whereas 22 patients (44.9%) 
were free of complications.
One patient had an intraoperative complication due to an iliac artery injury during the pelvic 
lymphadenectomy but no laparoconversion were necessary neither transfusion. No bowel or 
bladder injury was reported.
Two patients (3.3%) had severe postoperative complications (defined as Clavien-Dindo ≥III and/
or CTCAE ≥3). One patient had a peritonitis secondary to a lymphocyst infection which was 
radiologically drained 2 weeks after surgery. One patient had a hydronephrosis due to a unilateral 
ureteral stenosis at 7 weeks after surgery. No pulmonary embolism or death were reported.
The urinary complications were the most frequent complications with 19 complications 
occurred in 14 patients (28.6%). Most of them were minor urinary infection (8/14) which 
occurred during the first 2 weeks after surgery. Dysuria was observed in 4 patients (8.2%). 
Thirteen patients (26.5%) had 17 lymphovascular complications. Lower limbs lymphedema 
was unilateral in 3 cases and bilateral in 5 cases. Seven patients (14.3%) had 7 non-severe 
neurologic complications. Among them, one patient kept paresthesia of the genito-femoral 
nerve 16 weeks after surgery and one patient had a unilateral little weakness of the obturator 
nerve 13 weeks after surgery. Overall complications are summarised in Table 2.
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Total population (n=49) Values
Number of removed nodes
Number of SLN per patient 3 (1–8)
Number of non-SLN per patient if PL done 13 (4–32)
Final pathologic exam
Tumor size (mm)
≤20 45 (91.8)
>20 4 (8.2)
LVSI
Yes 9 (18.4)
No 40 (81.6)
SLN status
Positive 0
Negative 49 (100.0)
Values are presented as number of patients (%) or median (range).
BMI, body mass index; LARVT, laparoscopic-assisted radical vaginal trachelectomy; LEEP, loop electrical excision 
procedure; LVSI, lymphovascular space invasion; PL, pelvic lymphadenectomy; SLN, sentinel lymph node.
Table 1. (Continued) Clinicopathologic and surgical characteristics of patients
3. Predictive factors of postoperative complications
In univariate analysis, postoperative complications were more common in patients with IB1 
FIGO stage (26/41 patients) than in patients with IA1–IA2 FIGO stage (1/7 patients), 63.4% vs. 
12.5%, respectively (p=0.008). Patients with previous pelvic surgery had more postoperative 
complications than patients who never had pelvic surgery, 75% vs. 45.5%, respectively 
(p=0.05). Patients who have been operated in type 2 inclusion center seemed to have less 
postoperative complications (10/24 patients, 41.7%) than patients from type 1 inclusion 
center (17/25 patients, 68%).
The risk of postoperative complications was not associated with the age at diagnosis, the tumor 
histology, the number of SLN or non-SLN removed and the topography of SLNs (Table 3).
Multivariate logistic regression determined 2 factors independently associated with the 
risk of postoperative complications: history of previous pelvic surgery (adjusted odds 
ratio [aOR]=13.17; 95% confidence interval [CI]=1.38–125.98; p=0.03) and IB1 FIGO stage 
(aOR=11.72; 95% CI=1.22–112.32; p=0.03). Patients who have been operated in in type 2 
inclusion center had lower risk of postoperative complications (aOR=0.19; 95% CI=0.04–
0.97; p=0.046) (Table 4).
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Table 2. Postoperative complications
Variable (n=49) Values
Number of complications per patient
None 22 (44.9)
1 16 (32.7)
2 7 (14.3)
3 4 (8.2)
Clavien-Dindo classification (maximal grade/patient)
None 22 (44.9)
I 9 (18.4)
II 9 (18.4)
IIIa 0
IIIb 1 (2.0)
IVa 0
CTCAE classification (maximal grade/patient)
None 22 (44.9)
1 7 (14.3)
2 10 (20.4)
3 1 (2.0)
4 0
Urinary tract complications
Lower tract urinary infections 8 (16.3)
Upper tract urinary infections 1 (2.0)
Dysuria 4 (8.2)
Stress urinary incontinence 4 (8.2)
Hydronephrosis 1 (2.0)
Lymphovascular complications
Lower limb lymphedema 9 (18.4)
Lymphocyst 5 (10.2)
Other 2 (4.1)
Neurologic complications
Obturator nerve 4 (8.2)
Genito-femoral nerve 3 (6.1)
Thrombo-embolic complications
Limb venous thrombosis 0
Pulmonary embolism 0
Values are presented as number of patients (%).
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Table 3. Univariate analysis of risk factors of postoperative morbidity
Predictive variable Group without complications (n=22) Group with complications (n=27) p
Type of inclusion center 0.06
Type 1 8 (36.4) 17 (63)
Type 2 14 (63.6) 10 (37)
Age (yr)
Mean 32.9±5.2 (25–46) 32.6±5.4 (22–42) 0.82
<30 6 (27.3) 8 (29.6) 0.86
≥30 16 (72.7) 19 (70.4)
BMI (kg/m2)
Mean 22.8±5.6 (15.8–38.2) 22.1±3.8 (17–32.8) 0.63
<18.5 5 (22.7) 2 (7.4) 0.13
≥18.5 and <25 10 (45.5) 21 (77.8)
≥25 and <30 4 (18.2) 2 (7.4)
≥30 3 (13.6) 2 (7.4)
Parity 0.48
0 10 (45.5) 15 (55.6)
≥1 12 (54.5) 12 (44.4)
History of previous pelvic surgery 0.05
0 18 (81.8) 15 (55.6)
≥1 4 (18.2) 12 (44.4)
FIGO stage 0.008
IA1 with emboli - IA2 7 (31.8) 1 (3.7)
IB1 15 (68.2) 26 (96.3)
Histology 0.59
Squamous cell carcinoma 15 (68.2) 16 (59.3)
Adenocarcinoma 7 (31.8) 10 (37.0)
Adenosquamous 0 1 (3.7)
Presence of LVSI in the biopsy 0.88
Yes 4 (18.2) 4 (14.8)
No 17 (77.3) 21 (77.8)
Not specified 1 (4.5) 2 (7.4)
Tumor size at preoperative imagery (mm) 0.93
≤20 mm 16 (72.7) 19 (70.4)
>20 mm 2 (9.1) 2 (7.4)
Not specified 4 (18.2) 6 (22.2)
Preoperative LEEP 0.27
Yes 13 (59.1) 20 (74.1)
No 9 (40.9) 7 (25.9)
Type of surgical approach 0.06
LARVT 22 (100.0) 23 (85.2)
Laparoscopy 0 4 (14.8)
Mean length of operative time (min) 270.4±92.7 (211–435) 262.6±52.7 (165–360) 0.81
Type of lymph node staging 0.41
SLN alone 5 (22.7) 9 (33.3)
SLN + PL 17 (77.3) 18 (66.7)
SLN detection 0.88
Unilateral 1 (4.5) 1 (3.7)
Bilateral 21 (95.5) 26 (96.3)
Type of SLN 0.5
Blue and hot 57 (68.7) 67 (69.8)
Hot 13 (15.7) 19 (19.8)
Blue 13 (15.7) 10 (10.4)
Total 83 (100.0) 96 (100.0)
Topography of SLN per patient 0.35
Patients with SLN only in Ilio-obturator/external iliac area 18 (81.8) 19 (70.4)
Patients with at least one SLN in atypical area 4 (18.2) 8 (29.6)
(continued to the next page)
4. Follow-up and oncologic outcomes
The median follow-up was 46 months (1–85). Only one patient had a secondary simple 
hysterectomy for non-oncologic reasons 5 months later. During follow-up, one patient was 
lost to follow-up (2%) and 3 patients had recurrent disease (6.1%). The first patient had a 
local recurrence at 13 months after surgery on the upper part of the vagina and necessitated 
a secondary surgery with radical hysterectomy and concomitant chemoradiotherapy. The 
second patient had a local recurrence on the upper part of the vagina 31 months after surgery 
and the third patient had one metastatic inguinal node 55 months after surgery. These 2 
patients received radiotherapy and chemotherapy without secondary surgery. For these 
3 patients, the tumor size were respectively 13, 15, and 18 mm. One patient died of breast 
cancer 41 months after surgery, without any sign of recurrence of cervical disease.
Overall survival and recurrence-free survival rates did not significantly differ at 5-year of 
follow-up between patients with and without complication (100% vs. 95.5%, p=0.33 and 
96.3% vs. 90.9%, p=0.27, respectively).
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Predictive variable Group without complications (n=22) Group with complications (n=27) p
Number of removed nodes 0.76
Number of SLN per patient 3.8±1.7 (1–8) 3.9±2 (2–8)
Number of non-SLN per patient if PL done 15.3±6.5 (4–27) 14.6±6.7 (8–32)
Final pathologic exam
Tumor size (mm) 0.21
≤20 19 (86.4) 26 (96.3)
>20 3 (13.6) 1 (3.7)
LVSI 0.48
Yes 5 (22.7) 4 (14.8)
No 17 (77.3) 23 (85.2)
Values are presented as number of patients (%) or median (range).
BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; LARVT, laparoscopic-assisted radical vaginal trachelectomy; LEEP, loop 
electrical excision procedure; LVSI, lymphovascular space invasion; PL, pelvic lymphadenectomy; SLN, sentinel lymph node.
Table 3. (Continued) Univariate analysis of risk factors of postoperative morbidity
Table 4. Multivariate analysis of risk factors of postoperative morbidity
Variable aOR 95% CI p
Type of inclusion center
Type 1 1
Type 2 0.19 0.04–0.97 0.046
BMI (kg/m2)
≥18.5 and <25 1
<18.5 0.39 0.05–2.85 0.35
≥25 and <30 0.06 0.01–1.07 0.06
≥30 0.1 0.01–2.5 0.16
History of previous pelvic surgery
0 1
≥1 13.17 1.38–125.98 0.03
FIGO stage
IA1 with emboli - IA2 1
IB1 11.72 1.22–112.32 0.03
Type of surgical approach
Laparoscopy 1
LARVT 0.01 0.00–2.83 0.11
aOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; FIGO, International Federation of 
Gynecology and Obstetrics; LARVT, laparoscopic-assisted radical vaginal trachelectomy.
DISCUSSION
RT is now widely proposed to young patients with early cervical cancer. Prospective data 
concerning postoperative morbidity and its potential impact on survival are lacking. We 
decided to perform a retrospective analysis on two databases coming from prospective trials 
on early cervical cancer.
This study shows that the overall rate of complications is important (55.1% of patients) but 
intraoperative and severe postoperative complications are rare, 2% and 4.1% respectively. The 
most frequent complication is urinary infection. Dysuria was recorded in 8.2% of women. 
These rates are comparable to those of radical hysterectomy [14,16,17] and RT appears as safe 
as radical hysterectomy for young patients who wish to preserve their fertility.
Only one intraoperative complication occurred and consisted in vessels injury during the 
nodal dissection. They are not linked to the trachelectomy itself but should be considered 
since the nodal dissection and preparation of obturator fossa are the first steps of the 
procedure. This rate is in accord with major papers. With Dargent's procedure, intraoperative 
complication rate was estimated at 3.7% in 1,364 patients [1,9,14,16,18-21]. Complications 
occurred during pelvic lymphadenectomy step with vessels injury and during vaginal step 
with bladder and ureteric injuries [11]. In a cohort of 107 abdominal RT, Li et al. [22] reported 
a lower intraoperative complication rate of 1.9%. However, intraoperative complications 
seem to be more severe by laparotomy [11].
In our series, 20.4% patients had at least a complication assessed grade ≥II according to 
Clavien-Dindo classification and 22.4% patients had at least a complication assessed grade ≥2 
according to the CTCAE classification. These postoperative morbidity rates were comparable 
to those found in literature [14,19,21,23,24].
One patient had a peritonitis secondary to a lymphocyst infection. This complication was 
also described by Sonoda et al. [3] in 2 cases, secondaries to a group B streptococcus and they 
hypothesised that there were a transvaginal contamination during the paravesical dissection.
We noted that 7 patients (14.3%) had 7 non-severe neurologic complications and this rate 
was similar to that found by Alexander-Sefre et al. (14%) [25] and inferior to that found by 
Lanowska et al. (21.7%) [21]. Irritation of the genitofemoral or obturator nerves may be 
induced by manipulation and direct thermal or electrical injury by monopolar diathermy. 
Using harmonic scalpel and bipolar diathermy may reduce such complications [25].
In this cohort, laparoscopic-assisted radical vaginal trachelectomy seemed to be a safer 
approach than total laparoscopic technique but only 4 patients had this last technique. 
Moreover, no patient had laparotomy, neither robotic-assisted technique. In case of multiple 
prior conisation that may induce a modification of the anatomy, Sonoda et al. [3] suggested 
that an abdominal approach should be better than a vaginal approach. However, we did 
not find a significant increased risk of complication if patients had a previous conisation. 
The multivariate analysis reported 2 risk factors of complications: previous pelvic surgery 
and stage IB1. These parameters are difficult to integrate in the decision-making process. 
As suggested by our results, RT performed in expert centers with high surgical skills may 
be associated with better surgical outcomes. These results are in concordance with the 
last ESGO guidelines which recommended that surgery for cervical cancer should be 
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performed by gynecologic oncologist and trained surgeon in a specialized team dedicated to 
management of gynecologic cancers [5].
During follow-up, 3 patients had recurrent disease (6.1%): two local recurrences and one 
locoregional recurrence. This recurrent rate was similar to that found in Vaginal RT series 
(4.8%–5.1%) [9,20], in LARVT series (5.2%) [14] and robotic series (5.2%) [10]. One 
recurrence occurred more than 4 years after RT and this highlights the need for long-term 
follow-up as already suggested by Plante et al. [20] and Hauerberg et al. [9]. Complications 
had no significant impact on survival.
Given the design of SENTICOL I and II, obstetrical data and outcomes were not specifically 
recorded and assessed, constituting the main weakness of this study. Another limitation of 
this study lies in the fact that some details of surgical procedure lacks, such as uterine artery 
preservation or placement of cerclage, due to this retrospective analyse. The strengths of 
this study are that all data related to postoperative morbidity were prospectively recorded 
in a quality-checked database and population study was homogenous with a long follow-
up. Moreover, patients came from multiple institutions taking in account different levels of 
surgical expertise and different levels of learning curve.
In conclusion, this study using prospective data, confirms that RT has few severe 
postoperative complications and few recurrences when classical indications are respected. 
RT appears as a safe and feasible alternative to spare fertility of young patients without 
increasing risk of complication comparatively to radical hysterectomy. Postoperative 
complications did not impact on oncologic outcomes. To guarantee best surgical outcomes, 
patients eligible for RT should be referred to expert center.
REFERENCES
 1. Dargent D, Martin X, Sacchetoni A, Mathevet P. Laparoscopic vaginal radical trachelectomy: a treatment 
to preserve the fertility of cervical carcinoma patients. Cancer 2000;88:1877-82. 
PUBMED | CROSSREF
 2. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Cancer stat facts: 
cervical cancer [Internet]. Bethesda, MD: National Cancer Institute; [cited 2018 Mar 5]. Available from: 
https://seer.cancer.gov/statfacts/html/cervix.html.
 3. Sonoda Y, Abu-Rustum NR, Gemignani ML, Chi DS, Brown CL, Poynor EA, et al. A fertility-sparing 
alternative to radical hysterectomy: how many patients may be eligible? Gynecol Oncol 2004;95:534-8. 
PUBMED | CROSSREF
 4. Roy M, Plante M. Pregnancies after radical vaginal trachelectomy for early-stage cervical cancer. Am J 
Obstet Gynecol 1998;179:1491-6. 
PUBMED | CROSSREF
 5. Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European 
Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society 
of Pathology guidelines for the management of patients with cervical cancer. Int J Gynecol Cancer 
2018;28:641-55. 
PUBMED | CROSSREF
 6. Bentivegna E, Maulard A, Pautier P, Chargari C, Gouy S, Morice P. Fertility results and pregnancy 
outcomes after conservative treatment of cervical cancer: a systematic review of the literature. Fertil Steril 
2016;106:1195-1211.e5. 
PUBMED | CROSSREF
 7. Yoon A, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, et al. Perioperative outcomes of radical trachelectomy 
in early-stage cervical cancer: vaginal versus laparoscopic approaches. Int J Gynecol Cancer 2015;25:1051-7. 
PUBMED | CROSSREF
11/13https://ejgo.org https://doi.org/10.3802/jgo.2019.30.e34
Morbidity of radical trachelectomy: a French prospective multicentric cohort
 8. Vieira MA, Rendón GJ, Munsell M, Echeverri L, Frumovitz M, Schmeler KM, et al. Radical trachelectomy 
in early-stage cervical cancer: a comparison of laparotomy and minimally invasive surgery. Gynecol Oncol 
2015;138:585-9. 
PUBMED | CROSSREF
 9. Hauerberg L, Høgdall C, Loft A, Ottosen C, Bjoern SF, Mosgaard BJ, et al. Vaginal radical trachelectomy 
for early stage cervical cancer. Results of the Danish National Single Center Strategy. Gynecol Oncol 
2015;138:304-10. 
PUBMED | CROSSREF
 10. Johansen G, Lönnerfors C, Falconer H, Persson J. Reproductive and oncologic outcome following robot-
assisted laparoscopic radical trachelectomy for early stage cervical cancer. Gynecol Oncol 2016;141:160-5. 
PUBMED | CROSSREF
 11. Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P. Oncological outcomes after fertility-
sparing surgery for cervical cancer: a systematic review. Lancet Oncol 2016;17:e240-53. 
PUBMED | CROSSREF
 12. Lécuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Daraï E, et al. Bilateral negative sentinel nodes 
accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL 
study. J Clin Oncol 2011;29:1686-91. 
PUBMED | CROSSREF
 13. Mathevet P, Lecuru F, Magaud L, Bouttitie F. Sentinel lymph node biopsy for early cervical cancer: results 
of a randomized prospective, multicenter study (SENTICOL 2) comparing adding pelvic lymph node 
dissection vs sentinel node biopsy only. Gynecol Oncol 2017;145 Suppl 1:2-3. 
CROSSREF
 14. Marchiole P, Benchaib M, Buenerd A, Lazlo E, Dargent D, Mathevet P. Oncological safety of laparoscopic-
assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with 
laparoscopic-assisted vaginal radical hysterectomy (LARVH). Gynecol Oncol 2007;106:132-41. 
PUBMED | CROSSREF
 15. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with 
evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13. 
PUBMED | CROSSREF
 16. Beiner ME, Hauspy J, Rosen B, Murphy J, Laframboise S, Nofech-Mozes S, et al. Radical vaginal 
trachelectomy vs. radical hysterectomy for small early stage cervical cancer: a matched case-control study. 
Gynecol Oncol 2008;110:168-71. 
PUBMED | CROSSREF
 17. Zhang D, Li J, Ge H, Ju X, Chen X, Tang J, et al. Surgical and pathological outcomes of abdominal radical 
trachelectomy versus hysterectomy for early-stage cervical cancer. Int J Gynecol Cancer 2014;24:1312-8. 
PUBMED | CROSSREF
 18. Shepherd JH, Spencer C, Herod J, Ind TE. Radical vaginal trachelectomy as a fertility-sparing procedure 
in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women. BJOG 
2006;113:719-24. 
PUBMED | CROSSREF
 19. Hertel H, Köhler C, Grund D, Hillemanns P, Possover M, Michels W, et al. Radical vaginal trachelectomy 
(RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 
patients with early cervical cancer. Gynecol Oncol 2006;103:506-11. 
PUBMED | CROSSREF
 20. Plante M, Gregoire J, Renaud MC, Roy M. The vaginal radical trachelectomy: an update of a series of 125 
cases and 106 pregnancies. Gynecol Oncol 2011;121:290-7. 
PUBMED | CROSSREF
 21. Lanowska M, Mangler M, Spek A, Grittner U, Hasenbein K, Chiantera V, et al. Radical vaginal 
trachelectomy (RVT) combined with laparoscopic lymphadenectomy: prospective study of 225 patients 
with early-stage cervical cancer. Int J Gynecol Cancer 2011;21:1458-64. 
PUBMED | CROSSREF
 22. Li X, Li J, Wen H, Ju X, Chen X, Xia L, et al. The survival rate and surgical morbidity of abdominal radical 
trachelectomy versus abdominal radical hysterectomy for stage IB1 cervical cancer. Ann Surg Oncol 
2016;23:2953-8. 
PUBMED | CROSSREF
 23. Kucukmetin A, Biliatis I, Ratnavelu N, Patel A, Cameron I, Ralte A, et al. Laparoscopic radical 
trachelectomy is an alternative to laparotomy with improved perioperative outcomes in patients with 
early-stage cervical cancer. Int J Gynecol Cancer 2014;24:135-40. 
PUBMED | CROSSREF
12/13https://ejgo.org https://doi.org/10.3802/jgo.2019.30.e34
Morbidity of radical trachelectomy: a French prospective multicentric cohort
 24. Pareja R, Rendón GJ, Sanz-Lomana CM, Monzón O, Ramirez PT. Surgical, oncological, and obstetrical 
outcomes after abdominal radical trachelectomy - a systematic literature review. Gynecol Oncol 
2013;131:77-82. 
PUBMED | CROSSREF
 25. Alexander-Sefre F, Chee N, Spencer C, Menon U, Shepherd JH. Surgical morbidity associated with radical 
trachelectomy and radical hysterectomy. Gynecol Oncol 2006;101:450-4. 
PUBMED | CROSSREF
13/13https://ejgo.org https://doi.org/10.3802/jgo.2019.30.e34
Morbidity of radical trachelectomy: a French prospective multicentric cohort
